当前位置:首页 - 行情中心 - 京新药业(002020) - 财务分析 - 现金流量表

京新药业

(002020)

  

流通市值:92.74亿  总市值:110.30亿
流通股本:7.24亿   总股本:8.61亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,838,651,137.391,890,634,479.61,038,425,6333,800,884,222.9
收到的税费返还57,322,939.5122,932,227.8711,847,416.9474,576,835.99
收到其他与经营活动有关的现金168,847,038.65142,804,516.3647,488,848.36147,723,068.54
经营活动现金流入的平衡项目0000
经营活动现金流入小计3,064,821,115.552,056,371,223.831,097,761,898.34,023,184,127.43
购买商品、接受劳务支付的现金1,100,794,598.42684,835,942.18317,461,282.781,491,461,609.38
支付给职工以及为职工支付的现金459,664,700.7325,047,765.25160,476,360.46603,829,028.95
支付的各项税费285,627,033.66212,558,493.83100,271,356.3320,073,943.44
支付其他与经营活动有关的现金606,041,569.84357,763,754.32166,023,871.44814,981,179.73
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,452,127,902.621,580,205,955.58744,232,870.983,230,345,761.5
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额612,693,212.93476,165,268.25353,529,027.32792,838,365.93
二、投资活动产生的现金流量:
收回投资收到的现金3,263,627,519.331,515,000,000480,000,000915,000,000
取得投资收益收到的现金9,941,772.483,586,970.742,772,965.9431,853,562.49
处置固定资产、无形资产和其他长期资产收回的现金净额1,402,300.566,655-10,265,007
收到的其他与投资活动有关的现金2,400,1002,400,100--
投资活动现金流入的平衡项目0000
投资活动现金流入小计3,277,371,692.311,521,053,725.74482,772,965.94957,118,569.49
购建固定资产、无形资产和其他长期资产支付的现金181,753,715.24138,954,069.6177,479,367.63519,514,938.58
投资支付的现金4,623,863,145.212,636,000,000110,000,0001,175,196,224.99
投资活动现金流出的平衡项目0000
投资活动现金流出小计4,805,616,860.452,774,954,069.61187,479,367.631,694,711,163.57
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,528,245,168.14-1,253,900,343.87295,293,598.31-737,592,594.08
三、筹资活动产生的现金流量:
吸收投资收到的现金400,000400,000400,000-
其中:子公司吸收少数股东投资收到的现金400,000400,000400,000-
取得借款收到的现金569,154,941.68457,786,066.66199,710,316.66585,002,153.6
收到其他与筹资活动有关的现金---56,320.82
筹资活动现金流入平衡项目0000
筹资活动现金流入小计569,554,941.68458,186,066.66200,110,316.66585,058,474.42
偿还债务支付的现金452,000,000280,000,000150,000,000550,000,000
分配股利、利润或偿付利息支付的现金261,462,561.24261,462,561.24-262,332,699.84
其中:子公司支付给少数股东的股利、利润3,153,819.243,153,819.24-4,023,957.84
支付其他与筹资活动有关的现金11,971,980.6110,324,115.881,444,653.9118,334,157.57
筹资活动现金流出平衡项目0000
筹资活动现金流出小计725,434,541.85551,786,677.12151,444,653.91830,666,857.41
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-155,879,600.17-93,600,610.4648,665,662.75-245,608,382.99
四、汇率变动对现金及现金等价物的影响-400,802.793,484,141.451,333,726.132,713,697.14
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,071,832,358.17-867,851,544.63698,822,014.51-187,648,914
加:期初现金及现金等价物余额1,276,018,367.751,276,018,367.751,276,018,367.751,463,667,281.75
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额204,186,009.58408,166,823.121,974,840,382.261,276,018,367.75
补充资料:
净利润-405,870,318.95-623,417,572.86
资产减值准备-11,208,317.97-26,282,948.06
固定资产和投资性房地产折旧-127,570,034.84-184,530,937.01
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-127,570,034.84-184,530,937.01
无形资产摊销-10,850,129.06-21,260,002.35
长期待摊费用摊销-6,550,267.44-11,549,034.64
处置固定资产、无形资产和其他长期资产的损失--239,398.95--6,859,767.39
固定资产报废损失-17,670.24-6,326.68
公允价值变动损失--853,424.66--36,770,941.18
财务费用-3,952,004.51-3,880,970.41
投资损失-132,060.33--6,440,588.27
递延所得税-1,171,993.58-2,838,939.25
其中:递延所得税资产减少--6,614,911.64--5,877,260.93
递延所得税负债增加-7,786,905.22-8,716,200.18
存货的减少--48,631,951.73-123,041,526.91
经营性应收项目的减少--111,443,529.15--93,479,033.3
经营性应付项目的增加-63,684,977.36--74,580,213.07
现金的期末余额-408,166,823.12-1,276,018,367.75
减:现金的期初余额-1,276,018,367.75-1,463,667,281.75
公告日期2024-10-252024-08-152024-04-242024-03-30
审计意见(境内)标准无保留意见
TOP↑